Glenmede Disciplined US Small Cap Eq Ptf holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Glenmede Disciplined U.S. Small Cap Equity Portfolio GQSCX
- NAV / 1-Day Return $19.58 / −0.05 %
- Fund Size $9.4M
- Adjusted Expense Ratio 0.850%
- Net Expense Ratio 0.850%
- Fee Level: Distribution Below Average
- Share Class Type No Load
- Morningstar Category Small Value
- Equity Style Box (Funds) Small Value
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.45%
- Turnover Ratio 92%
Morningstar’s Analysis GQSCX
Will GQSCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 9.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
10x Genomics Inc Ordinary Shares - Class A | 1.74 | 122,076 | Healthcare |
CareDx Inc | 0.96 | 67,275 | Healthcare |
Recursion Pharmaceuticals Inc Class A | 0.86 | 60,410 | Healthcare |
Coursera Inc | 0.86 | 60,324 | Consumer Defensive |
Green Plains Inc | 0.85 | 60,059 | Basic Materials |
PRA Group Inc | 0.85 | 59,971 | Financial Services |
Covista Inc | 0.84 | 59,267 | Consumer Defensive |
HealthStream Inc | 0.84 | 59,182 | Healthcare |
AMN Healthcare Services Inc | 0.84 | 59,114 | Healthcare |
MiMedx Group Inc | 0.83 | 58,390 | Healthcare |